F-star Biotech
Developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. Learn more
Launch date
Employees
Market cap
AUD242m
Enterprise valuation
AUD207m (Public information from Mar 2023)
Share price
$7.12 FSTX
Babraham England (HQ)
Authorizing premium user...